Michalis L. Kosmidis

Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients

Eleni Kampylafka, Michalis L. Kosmidis, Demosthenes B. Panagiotakos et al. · PLoS ONE · 2013 · 115 citations · Full text

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study

Michalis L. Kosmidis, Harry Alexopoulos, Ioanna Mamali et al. · Journal of the Neurological Sciences · 2014 · 92 citations

Skin Biopsies, Pain Syndrome, Peripheral Nerve Injury +8

The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study

Michalis L. Kosmidis, Harry Alexopoulos, Athanasios G. Tzioufas et al. · Journal of the Neurological Sciences · 2013 · 60 citations

Inflammation, Autoimmune Disease, Immunodeficiencies +11

The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study.

Eleni Kampylafka, Michalis L. Kosmidis, Demosthenes B. Panagiotakos et al. · PubMed · 2012 · 36 citations

Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis

Michalis L. Kosmidis, Dimitris Pikazis, Panayotis G. Vlachoyiannopoulos et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 24 citations · Full text